Close Menu
News Article

Institute Statement: Research Integrity Inquiry

Texas Biomed and the U.S. Office of Research Integrity (ORI) conducted an inquiry, confirming that a study completed by Dr. Deepak Kaushal prior to his tenure with Texas Biomed included study information/data that was inaccurately represented and this action met the ORI definition of “research misconduct”. The full summary from ORI is here:

ORI gave Dr. Kaushal the minimum consequences. This was a first-time incident, and to our knowledge, the only time this has happened in Dr. Kaushal’s lab. Dr. Kaushal retracted the paper that featured this data and corrected the study using appropriate study implementation. The results were exactly the same. Study results from this repeat study have been published ( Data from all studies carried out at Texas Biomed have been reviewed and found to be accurate.

In addition to ORI oversight, Dr. Kaushal has received internal consequences, including significant oversight of his lab. Texas Biomed is confident that this will not happen again and that Dr. Kaushal can continue to lead the Southwest National Primate Research Center capably and with integrity.

– Dr. Larry S. Schlesinger, Texas Biomed President/CEO  


Company Contact:

Lisa Cruz,

Vice President, Communications



Texas Biomed is one of the world’s leading independent biomedical research institutions dedicated to eradicating infection and advancing health worldwide through innovative biomedical research. Texas Biomed partners with researchers and institutions around the world to develop vaccines and therapeutics against viral pathogens causing AIDS, hepatitis, hemorrhagic fever, tuberculosis and parasitic diseases responsible for malaria and schistosomiasis disease. The Institute has programs in host-pathogen interaction, disease intervention and prevention, and population health to understand the links between infectious diseases and other diseases such as aging, cardiovascular disease, diabetes and obesity. For more information on Texas Biomed, go to